File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Low-dose nivolumab induced remission in refractory classical Hodgkin lymphoma

TitleLow-dose nivolumab induced remission in refractory classical Hodgkin lymphoma
Authors
Hwang, YYGKhong, PLKwong, YL
Issue Date2017
Citation
Annals of Hematology, 2017, v. 96, p. 1219-1220 How to Cite?
DOI: http://dx.doi.org/10.1007/s00277-017-3007-9
Persistent Identifierhttp://hdl.handle.net/10722/244899
ISSN
0939-5555
2021 Impact Factor: 4.030
2020 SCImago Journal Rankings: 1.079
ISI Accession Number ID
WOS:000403078900022

 

DC FieldValueLanguage
dc.contributor.authorHwang, YYG-
dc.contributor.authorKhong, PL-
dc.contributor.authorKwong, YL-
dc.date.accessioned2017-09-18T02:01:05Z-
dc.date.available2017-09-18T02:01:05Z-
dc.date.issued2017-
dc.identifier.citationAnnals of Hematology, 2017, v. 96, p. 1219-1220-
dc.identifier.issn0939-5555-
dc.identifier.urihttp://hdl.handle.net/10722/244899-
dc.languageeng-
dc.relation.ispartofAnnals of Hematology-
dc.titleLow-dose nivolumab induced remission in refractory classical Hodgkin lymphoma-
dc.typeArticle-
dc.identifier.emailHwang, YYG: yyhwang@hku.hk-
dc.identifier.emailKhong, PL: plkhong@hku.hk-
dc.identifier.emailKwong, YL: ylkwong@hkucc.hku.hk-
dc.identifier.authorityKhong, PL=rp00467-
dc.identifier.authorityKwong, YL=rp00358-
dc.identifier.doi10.1007/s00277-017-3007-9-
dc.identifier.scopuseid_2-s2.0-85018820016-
dc.identifier.hkuros278651-
dc.identifier.volume96-
dc.identifier.spage1219-
dc.identifier.epage1220-
dc.identifier.eissn1432-0584-
dc.identifier.isiWOS:000403078900022-
dc.identifier.issnl0939-5555-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats